Pfizer
PFE
PFE
3,092 hedge funds and large institutions have $161B invested in Pfizer in 2023 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 1,365 increasing their positions, 1,313 reducing their positions, and 232 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less call options, than puts
Call options by funds: $1.55B | Put options by funds: $2.08B
40% less first-time investments, than exits
New positions opened: 139 | Existing positions closed: 232
59% less funds holding in top 10
Funds holding in top 10: 193 → 80 (-113)
Holders
3,092
Holding in Top 10
80
Calls
$1.55B
Puts
$2.08B
Top Buyers
| 1 | +$800M | |
| 2 | +$452M | |
| 3 | +$429M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$276M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$274M |
Top Sellers
| 1 | -$1B | |
| 2 | -$739M | |
| 3 | -$546M | |
| 4 |
Barclays
London,
United Kingdom
|
-$242M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$214M |